Article
Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.
The Lancet. Neurology - 1 Jun 2020
Quiroz Yakeel T, Zetterberg Henrik, Reiman Eric M, Chen Yinghua, Su Yi, Fox-Fuller Joshua T, Garcia Gloria, Villegas Andres, Sepulveda-Falla Diego, Villada Marina, Arboleda-Velasquez Joseph F, Guzmán-Vélez Edmarie, Vila-Castelar Clara, Gordon Brian A, Schultz Stephanie A, Protas Hillary D, Ghisays Valentina, Giraldo Margarita, Tirado Victoria, Baena Ana, Munoz Claudia, Rios-Romenets Silvia, Tariot Pierre N, Blennow Kaj, Lopera Francisco
Abstract excerpt
BACKGROUND: Neurofilament light chain (NfL) is a promising biomarker of active axonal injury and neuronal degeneration. We aimed to characterise cross-sectional and longitudinal plasma NfL measurements and determine the age at which NfL concentrations begin to differentiate between carriers of the presenilin 1 (PSEN1) E280A (Glu280Ala) mutation and age-matched non-carriers from the Colombian autosomal dominant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
